|
|
|||
| |||||||||||||||||||||||||||||||||||||||||||||||
This spring,
Medical Processes as Intellectual Property
The LabCorp Case
Implications of Process Patents for Clinical Medicine
Source Information
From the Division of Pharmacoepidemiology and Pharmacoeconomics, Brigham and Women's Hospital (A.S.K.), and the Department of Health Policy and Management, Harvard School of Public Health (M.M.M.) both in Boston.
Related Letters:
Medical-Process Patents
Klein R. D.
Extract |
Full Text |
PDF
N Engl J Med 2007;
356:753-754, Feb 15, 2007.
Correspondence
This article has been cited by other articles:
HOME | SUBSCRIBE | SEARCH | CURRENT ISSUE | PAST ISSUES | COLLECTIONS | PRIVACY | HELP | beta.nejm.org Comments and questions? Please contact us. The New England Journal of Medicine is owned, published, and copyrighted © 2008 Massachusetts Medical Society. All rights reserved. |